Interactions between the intestinal microbiome and liver diseases.
about
STAT3, a Key Parameter of Cytokine-Driven Tissue Protection during Sterile Inflammation - the Case of Experimental Acetaminophen (Paracetamol)-Induced Liver DamageGut Microbiota and Lifestyle Interventions in NAFLDModulation of liver tolerance by conventional and nonconventional antigen-presenting cells and regulatory immune cellsChemoprevention of obesity-related liver carcinogenesis by using pharmaceutical and nutraceutical agentsThe Gastrointestinal Microbiome: Alcohol Effects on the Composition of Intestinal MicrobiotaGut epithelial barrier dysfunction in human immunodeficiency virus-hepatitis C virus coinfected patients: Influence on innate and acquired immunityNon-alcoholic fatty liver disease: what has changed in the treatment since the beginning?Alcoholic and non-alcoholic steatohepatitisRecent advances in characterizing the gastrointestinal microbiome in Crohn's disease: a systematic reviewSpontaneous bacterial peritonitis: The clinical challenge of a leaky gut and a cirrhotic liverGut microbiota and liver diseasesAlcoholic liver disease: the gut microbiome and liver cross talkMetabolic aspects of adult patients with nonalcoholic fatty liver diseaseImplication of the intestinal microbiome in complications of cirrhosisGut Microbiota and Host Reaction in Liver DiseasesGut microbiota and host metabolism in liver cirrhosisRole of farnesoid X receptor and bile acids in alcoholic liver diseaseTranscriptomic analysis of mouse liver reveals a potential hepato-enteric pathogenic mechanism in acute Toxoplasma gondii infectionGut Microbiota and Complications of Liver Disease.Developmental origins of NAFLD: a womb with a clue.15-hydroxyprostaglandin dehydrogenase (15-PGDH) prevents lipopolysaccharide (LPS)-induced acute liver injury.TRIF Differentially Regulates Hepatic Steatosis and Inflammation/Fibrosis in MiceCombination therapy: New hope for alcoholic hepatitis?Molecular mechanisms and new treatment strategies for non-alcoholic steatohepatitis (NASH)Gaps in Knowledge and Research Priorities for Alcoholic Hepatitis.Comparing the effects of acute alcohol consumption in germ-free and conventional mice: the role of the gut microbiotaFuture therapy of portal hypertension in liver cirrhosis - a guess.The dormant blood microbiome in chronic, inflammatory diseases.Enterotoxicity of a nonribosomal peptide causes antibiotic-associated colitis.Natural killer T cells play a necessary role in modulating of immune-mediated liver injury by gut microbiota.Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis.Fecal microbiota transplantation broadening its application beyond intestinal disorders.Innate immune signaling and gut-liver interactions in non-alcoholic fatty liver disease.Implication of gut microbiota in nonalcoholic fatty liver disease.Hepatic inflammation and fibrosis: functional links and key pathways.Intestinal transport and metabolism of bile acidsOral administration of Saccharomyces boulardii ameliorates carbon tetrachloride-induced liver fibrosis in rats via reducing intestinal permeability and modulating gut microbial composition.Does the microbiota play a role in the pathogenesis of autoimmune diseases?Commensal microbiota is hepatoprotective and prevents liver fibrosis in miceSmall-intestinal or colonic microbiota as a potential amino acid source in animals.
P2860
Q26747404-4926659A-6C3A-4D82-A345-88263D17B4D1Q26749783-115A8F93-B822-4BEB-8A39-4981F137E03DQ26753022-14663BA6-1D51-4069-BA86-41F0C2150BA4Q26772302-AA7C123C-6055-4059-8FAF-16EF634402E1Q26773227-43261C71-AAFA-4FFB-B656-2E8DCE5B1D97Q26773267-0D43912E-F7AD-4CE8-87D5-C7272F10177FQ26829503-57866016-964A-4866-9442-DFBCBEFC3F5AQ27000153-73A191FD-AF72-4C14-9E6E-4B4A08CC8F2EQ27000726-1C8FF250-2ED8-4C66-B3CC-87C91D0CD17CQ27001540-2C4216F7-F13B-4769-963D-C45D961035F6Q27015127-99EE2790-ABA3-4B8E-B471-CCDD5CC5500EQ27025627-CC2299A8-0A4F-4ECE-AF02-345A5EC67776Q28067490-84EE6158-4FCA-495F-A61F-BF5B67DBE559Q28068832-F3F31991-3E7F-4B9F-9D9C-49FF47F75BDAQ28083295-59E176F8-D547-44A7-9F5B-7F79DDC7953BQ28085155-4BDC9A4A-8E06-431F-BFAB-3F094F3D9589Q28086898-07D4117E-B88B-4DDD-BF54-A62E8BE33238Q28831391-D05CDF74-6798-40E7-9F55-94EAE3952E42Q30236024-03615180-D3A7-442E-83A1-4D379F25277EQ30241940-1E983F66-D1CF-4848-B212-1B40272EC797Q33579972-AC36E97D-5620-4CCC-BB33-7FF2B038A771Q33600346-427FF0DA-06C1-4B0B-9B42-D55E5D94C23DQ33746519-011A92BC-1AF6-4565-9E0F-A3668C639B0BQ33755566-2D197308-820A-4955-B3EC-851FC8172621Q33903664-96A14F34-1DE2-4C75-9EB8-5F78ABBF22F0Q34256050-43F3B341-F006-4239-B215-80BBD68CB6F2Q34446521-25803AFE-33DA-459C-B248-30E0DD928676Q34474989-F8D63616-3F02-40E6-87E1-379BE2D625C0Q34583682-57D178BA-7445-4CD4-B91C-C81659B7A9E8Q34590195-77696C47-76E4-4106-B969-87D53607B475Q34647371-64A4956D-6093-49FE-9352-4E9A1B2BFF93Q34667433-4D5373D4-A42B-43FA-BB66-432470FEDA12Q34750494-35F68C21-02E2-493F-89DD-58234CC37A1FQ35019282-7764AF4B-17DC-4C3E-9F2A-427DF4C0FDA3Q35213917-B30D72C0-3891-4DF0-A1DE-DDAD9148BF03Q35247159-D1D95F27-B3E6-4AE8-8902-E43972DC12CAQ35256601-2D3B4488-406A-4959-B186-3E084BF46BDFQ35443254-08928B23-2540-4152-B466-307EDD38F4BCQ35481673-248F284F-B33B-4784-AE03-1551DF081697Q35481701-70237977-ADF0-48C7-885E-D93F115D119E
P2860
Interactions between the intestinal microbiome and liver diseases.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Interactions between the intestinal microbiome and liver diseases.
@en
type
label
Interactions between the intestinal microbiome and liver diseases.
@en
prefLabel
Interactions between the intestinal microbiome and liver diseases.
@en
P2860
P1433
P1476
Interactions between the intestinal microbiome and liver diseases.
@en
P2093
Bernd Schnabl
P2860
P304
P356
10.1053/J.GASTRO.2014.01.020
P407
P577
2014-01-15T00:00:00Z